CClinicalTrials.gg
CompletedNCT03404219Updated Aug 10, 2021Results posted

Motivation and Skills Support (MASS)

An interventional study of Motivation and Skills Support (MASS) in Schizophrenia and Schizoaffective Disorder, sponsored by Boston University Charles River Campus. Completed at 2 sites in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2021-08-10.

Sponsored by Boston University Charles River Campus · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
31
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Social impairment contributes to more severe symptoms, higher rates of hospitalization, and increased disability in persons with schizophrenia. In this study the investigators will develop a smartphone application and test its impact on improving real-world social functioning in persons with schizophrenia. Findings from this study will allow researchers and clinicians to better understand ways to improve social skills and social motivation, two common problems in the daily lives of persons with schizophrenia. The investigators hope this mobile phone-based support application will ultimately contribute to increased access to effective treatments for social functioning in this population.

Read the detailed description

This project will involve an examination of the impact of a mobile intervention to improve social functioning in schizophrenia using an evidence-based treatment framework to target deficits in social skills and social motivation. Social impairment is a key characteristic of schizophrenia, present prior to onset and predictive of long-term course. The approach of the current project is to use Ecological Momentary Intervention (EMI), administered by mobile phone, to integrate features from social skills training (SST; an evidence-based treatment for schizophrenia) with social motivation support to improve social functioning. Aim 1 of the project will involve iterative development of the mobile application, using expert panel input and conducting usability testing to inform intervention content and approach. As an exploratory aim, social sensing technology (e.g., GPS and automated conversation detection) will be implemented to test the promise of this technology in identifying and intervening in social isolation. In Aim 2, 30 persons with schizophrenia will use the application over a 2-month period (data collection will occur across 2 sites). The investigators will test the impact of the application on social motivation (EMA reports of social anticipatory pleasure and presence of social interaction) across the intervention period. Investigators will also examine the impact on social functioning, measured with standard clinician-administered assessments, from baseline to 90-day follow-up. Additional clinical, neurocognitive, and social cognitive assessments will be gathered on study participants to identify potential moderators of outcome and predictors of application usability. This study will result in a better understanding of the feasibility and initial impact of a scalable intervention designed to support lasting, sustainable improvements in social functioning in schizophrenia.

02

Conditions studied

  • Schizophrenia
  • Schizoaffective Disorder
03

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

•All participants with schizophrenia or schizoaffective disorder (identified either by self-report and confirmatory chart diagnosis, or by using the Structured Clinical Interview for DSM-5 [SCID-5]) will be in good general physical health, between 18 and 65 years old (as to not confound developmental issues with our focus), and fluent in English. Subjects do not need to have a significant other in order to participate in the study.

Exclusion criteria

Exclusion Criteria:

•All participants with a current (past 6 months) substance use disorder, which will be determined by administration of the SCID-5, and self-reported current suicidal ideation with intent and/or a plan (assessed using attached instrument; i.e., "High" risk) or diagnosis of a neurological disorder.

04

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
31 participants (actual)

Study arms

  • Experimental
    Intervention

    Mobile intervention (i.e., Ecological momentary intervention \[EMI\]) addressing social motivation and social skills. Twice daily notifications sent to deliver EMI content. Social goal reminders and steps provided to support goal attainment. Social Skills Training content delivered via brief video clips.

    Behavioral: Motivation and Skills Support (MASS)

Interventions

  • BehavioralMotivation and Skills Support (MASS)

    Mobile phone-based application to support social skills and social motivation

05

What researchers measure

Primary outcomes

  1. Changes in Social Functioning as Measured by the Social Functioning Scale (SFS)

    The Social Functioning Scale (SFS; Birchwood, Smith, Cochrane, Wetton, and Copestake, 1990) is a validated measure of social functioning commonly used in schizophrenia research studies. This clinician-administered measure consists of 7 sub-scales where higher scores indicate better social functioning: Social Engagement/Withdrawal (7 items. Score range: 0-15), Interpersonal (5 items. Score range: 0-30), Prosocial (5 items. Score range: 0-66), Recreation (23 items. Score range: 0-48), Independence - competence (15 items. Score range: 0-39), Independence - performance (13 items. Score range: 0-39), and Employment (13 items. Score range is 0-6 if the participant is unemployed and 7-10 if the participant is employed). The total score is the sum of the 7 sub-scales (Possible range of 0-247) and higher scores indicate better functioning. The investigators will examine the difference in total score from baseline (study entry) to follow-up (3 months after study termination).

    Time frame: Baseline (study entry) and follow-up (3 months post-intervention)

  2. Changes in Social Engagement as Measured by the Quality of Life Scale (QLS) - Interpersonal Relations Subscale.

    The Heinrich Quality of Life Scale - Interpersonal Relations subscale (Heinrichs, Hanlon, \& Carpenter, 1984) is a validated measure of social engagement used in studies of schizophrenia. This clinician-administered measure consists of 8 items that address different facets of social engagement (e.g., social network, acquaintances, intimate relationships, social withdrawal). Possible scores range from 0-48 with higher scores indicating better outcomes. The investigators will administer this measure at baseline (study entry) and follow-up (3 months post-intervention).

    Time frame: Baseline (study entry) and follow-up (3 months post-intervention)

Secondary outcomes

  1. Changes in Experience-Sampling-Based Self-Reports of Social Appraisals

    The investigators will ask participants to report on positive social appraisals (unpublished measure) of recent interactions 2 times per day over the 2-month intervention period. Specific items and response options are the following: 1. "How well do you think you communicated in those conversations?" (from 1 \[I did not communicate well at all\] to 4 \[I communicated very well\]) 2. "To what extent were those interactions worth the effort?" (from 1 \[not worth the effort at all\] to 4 \[definitely worth the effort\]) 3. "What do you think other people thought of you in those conversations?" with response options ranging from 1 \[very unlikable\] to 4 \[very likable\]) We will average scores on the above items across all available time points (total possible time points = 120) to form a composite variable representing social appraisals. Higher scores represent more positive appraisals. Investigators will examine changes in appraisals over the intervention.

    Time frame: 2 times per day for 2 months (intervention period).

06

Results

Posted Aug 10, 2021

Participant flow

Participant flow — Overall Study
MilestoneIntervention Group
Started31
Completed31
Not completed0

Outcome measures

PrimaryChanges in Social Functioning as Measured by the Social Functioning Scale (SFS)

The Social Functioning Scale (SFS; Birchwood, Smith, Cochrane, Wetton, and Copestake, 1990) is a validated measure of social functioning commonly used in schizophrenia research studies. This clinician-administered measure consists of 7 sub-scales where higher scores indicate better social functioning: Social Engagement/Withdrawal (7 items. Score range: 0-15), Interpersonal (5 items. Score range: 0-30), Prosocial (5 items. Score range: 0-66), Recreation (23 items. Score range: 0-48), Independence - competence (15 items. Score range: 0-39), Independence - performance (13 items. Score range: 0-39), and Employment (13 items. Score range is 0-6 if the participant is unemployed and 7-10 if the participant is employed). The total score is the sum of the 7 sub-scales (Possible range of 0-247) and higher scores indicate better functioning. The investigators will examine the difference in total score from baseline (study entry) to follow-up (3 months after study termination).

Time frame:
Baseline (study entry) and follow-up (3 months post-intervention)
Reported as:
Mean · score on a scale
Changes in Social Functioning as Measured by the Social Functioning Scale (SFS)
score on a scaleIntervention Group
Changes in Social Functioning as Measured by the Social Functioning Scale (SFS)108.00 ± 7.13
Statistical analysis
  • Intervention Group · General Linear Model (repeated measures) · p = 0.09 · Mean difference (final values): 2.56
PrimaryChanges in Social Engagement as Measured by the Quality of Life Scale (QLS) - Interpersonal Relations Subscale.

The Heinrich Quality of Life Scale - Interpersonal Relations subscale (Heinrichs, Hanlon, \& Carpenter, 1984) is a validated measure of social engagement used in studies of schizophrenia. This clinician-administered measure consists of 8 items that address different facets of social engagement (e.g., social network, acquaintances, intimate relationships, social withdrawal). Possible scores range from 0-48 with higher scores indicating better outcomes. The investigators will administer this measure at baseline (study entry) and follow-up (3 months post-intervention).

Time frame:
Baseline (study entry) and follow-up (3 months post-intervention)
Reported as:
Mean · score on a scale
Changes in Social Engagement as Measured by the Quality of Life Scale (QLS) - Interpersonal Relations Subscale.
score on a scaleIntervention Group
Changes in Social Engagement as Measured by the Quality of Life Scale (QLS) - Interpersonal Relations Subscale.2.60 ± 1.36
SecondaryChanges in Experience-Sampling-Based Self-Reports of Social Appraisals

The investigators will ask participants to report on positive social appraisals (unpublished measure) of recent interactions 2 times per day over the 2-month intervention period. Specific items and response options are the following: 1. "How well do you think you communicated in those conversations?" (from 1 \[I did not communicate well at all\] to 4 \[I communicated very well\]) 2. "To what extent were those interactions worth the effort?" (from 1 \[not worth the effort at all\] to 4 \[definitely worth the effort\]) 3. "What do you think other people thought of you in those conversations?" with response options ranging from 1 \[very unlikable\] to 4 \[very likable\]) We will average scores on the above items across all available time points (total possible time points = 120) to form a composite variable representing social appraisals. Higher scores represent more positive appraisals. Investigators will examine changes in appraisals over the intervention.

Time frame:
2 times per day for 2 months (intervention period).
Reported as:
Mean · score on a scale
Changes in Experience-Sampling-Based Self-Reports of Social Appraisals
score on a scaleIntervention
Changes in Experience-Sampling-Based Self-Reports of Social Appraisals1.35 ± 0.64

Adverse events

Collected over Adverse event data were collected over the full course of the study (total frame = 5 months).. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention Group0/31 (0%)0/31 (0%)0/31 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Intervention Group
Mean46.097 (22 to 65)
Sex/Gender, Customized
Sex/Gender, Customized(Participants)Intervention Group
Gender — Female14
Gender — Male16
Gender — Unknown1
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Intervention Group
Hispanic or Latino1
Not Hispanic or Latino30
Unknown or Not Reported0
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Intervention Group
American Indian or Alaska Native0
Asian9
Native Hawaiian or Other Pacific Islander0
Black or African American5
White14
More than one race3
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Intervention Group
United States31
07

Study locations

2 sites
  • San Francisco State University
    San Francisco, California 94132, United States
  • Boston University
    Boston, Massachusetts 02215, United States
08

References and documents

Publications

  • Fulford D, Gard DE, Mueser KT, Mote J, Gill K, Leung L, Mow J. Preliminary Outcomes of an Ecological Momentary Intervention for Social Functioning in Schizophrenia: Pre-Post Study of the Motivation and Skills Support App. JMIR Ment Health. 2021 Jun 15;8(6):e27475. doi: 10.2196/27475. PubMed 34128812 ↗

Study documents

  • Protocol and statistical analysis plan · Apr 8, 2020
  • Informed consent form · Aug 7, 2019

Documents are hosted by the registry — open the source record to download them.

09

Registry details

Key details

Study ID
NCT03404219
Lead sponsor
Boston University Charles River Campus
Collaborators
San Francisco State University
Responsible party
Daniel Fulford (Assistant Professor, Occupational Therapy and Rehabiltiation Sciences, Boston University Charles River Campus) — Principal investigator
First posted
Jan 19, 2018
Start date
Nov 1, 2018
Primary completion
May 11, 2020
Completion
May 11, 2020
Results posted
Aug 10, 2021
Last update
Aug 10, 2021

Study contacts

Daniel Fulford, PhD
principal investigator · CRC BU Univeristy

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion